{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:11:54Z","timestamp":1790248314339,"version":"4.1.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human leukocyte antigen (HLA) polymorphisms play a vital role in antiviral immunity, but their influence on COVID-19 severity differs significantly among ethnic groups. T-cell responses are essential for clearing SARS-CoV-2, yet the immunogenetic factors underlying the diverse clinical outcomes in COVID-19, especially in certain populations, are not fully understood. In a Kuwait-based cohort from national referral and public health facilities, we examined HLA allelic variants to identify potential protective or risk factors related to COVID-19 severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied 494 participants: 75 healthy controls and 419 COVID-19 patients, classified by severity (Recovered, Moderate, Severe, Critical\/ICU). HLA alleles at nine loci (HLA-A, -B, -C, -DRB1, -DRB3\/4\/5, -DQA1, -DQB1, -DPA1, -DPB1) were genotyped via next-generation sequencing. Associations with severity were tested using logistic regression, adjusting for age, sex, and ABO blood group, with the Severe\/ICU group as the reference. This was repeated, excluding controls from the reference, to separate severity effects from susceptibility to infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HLA genotype was successfully linked to complete clinical\/covariate data for 364 of 494 participants (74%; 60 Healthy, 77 Recovered, 125 Moderate, 66 Severe, 36 ICU), though linkage success was lower among ICU patients (47%) than other strata (75\u201382%), a difference we consider more likely attributable to attrition during critical care than to allele-related bias. Among these 364 participants, 22 HLA alleles spanning all nine genotyped loci showed nominal association with severe\/critical disease (P &amp;lt; 0.10) in the primary model, predominantly risk-conferring: HLA-C*06:02:01 (OR 2.50, 95% CI 1.43\u20134.36, P = 0.001), HLA-DQB1*02:02:01 (OR 2.25, 1.31\u20133.88, P = 0.003), HLA-DRB1*15:03:01 (OR 4.65, 1.38\u201315.67, P = 0.013), HLA-A*29:02:01 (OR 14.11, 1.43\u2013138.81, P = 0.023), and HLA-B*13:02:01 (OR 12.78, 1.31\u2013124.18, P = 0.028), among others; one protective association was identified, HLA-A*31:01:02 (OR 0.26, 0.08\u20130.83, P = 0.023). These five associations remained directionally concordant in the sensitivity analysis excluding Healthy controls, whereas several weaker associations did not. None survived correction for multiple testing (FDR-adjusted q ranged from 0.36 to 0.99); a minimum-detectable-odds-ratio calculation indicated this cohort was powered to detect only large effects (OR \u2248 10 for a 1%-frequency allele after correction), consistent with underpowering rather than absence of true effect for several low-frequency candidates. Age remained the strongest independent predictor of severity (P &amp;lt; 0.001), whereas sex showed no significant association after adjustment (P = 0.289).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides a comprehensive characterisation of HLA allele frequencies in a Kuwait-based population, including their association with COVID-19 clinical outcomes. Age was a substantially more dominant determinant of COVID-19 severity than HLA genotype in this cohort. None of the identified HLA alleles retained statistical significance after correction for multiple testing; given both this power limitation and the absence of individual-level ancestry and vaccination data in a population with substantial genetic and demographic heterogeneity, these findings should be regarded as hypothesis-generating candidates for replication in larger, ancestry-adjusted, adequately powered cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1832089","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:35:45Z","timestamp":1788845745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["HLA allelic variation and COVID-19 severity in a Kuwait-based population: a high-resolution immunogenetic study"],"prefix":"10.3389","volume":"17","author":[{"given":"Monera","family":"Alrukhayes","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Health Sciences Center (HSC), Kuwait University","place":["Shadadiya, Kuwait"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Al-Shatti","sequence":"additional","affiliation":[{"name":"Immunology & HLA Laboratory, Kuwait Cancer Control Center, Ministry of Health","place":["Kuwait City, Kuwait"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almunther","family":"Alhasawi","sequence":"additional","affiliation":[{"name":"Department of Medicine , Hospital of Infectious Diseases","place":["Jahra, Kuwait"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Alghubayshi","sequence":"additional","affiliation":[{"name":"Research Center, King Fahad Specialist Hospital in Dammam (KFSH-D)","place":["Dammam, Saudi Arabia"]},{"name":"Research Program, Academic, Training, and Research Administration, Eastern Health Cluster","place":["Dammam, Saudi Arabia"]},{"name":"School of Systems Biology, George Mason University","place":["Fairfax, VA, United States"]},{"name":"Research and Development Department, GeneClinic","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Almsned","sequence":"additional","affiliation":[{"name":"Research Center, King Fahad Specialist Hospital in Dammam (KFSH-D)","place":["Dammam, Saudi Arabia"]},{"name":"Research Program, Academic, Training, and Research Administration, Eastern Health Cluster","place":["Dammam, Saudi Arabia"]},{"name":"School of Systems Biology, George Mason University","place":["Fairfax, VA, United States"]},{"name":"Research and Development Department, GeneClinic","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam M. Al","family":"Eissa","sequence":"additional","affiliation":[{"name":"College of Medicine, AlFaisal University","place":["Riyadh, Saudi Arabia"]},{"name":"Population Health Observatory, Ministry of Health","place":["Riyadh, Saudi Arabia"]},{"name":"Public Health Authority, Public Health Lab","place":["Riyadh, Saudi Arabia"]},{"name":"Research Department, King Khaled Eye Specialist Hospital (KKESH) Research Center","place":["Riyadh, Saudi Arabia"]},{"name":"School of Public Policy (KSPP), King Abdullah Petroleum Studies and Research Center (KAPSARC)","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25889","article-title":"C or r e sp ondence crystallopathies","volume":"69","author":"Zhao","year":"2020","journal-title":"J Med Virol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48879","article-title":"Perceptions of Saudis toward participating in the COVID-19 convalescent plasma clinical trial","volume":"15","author":"Al Eissa","year":"2023","journal-title":"Cureus"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines13101042","article-title":"Serological response to COVID-19 vaccination in Saudi Arabia: a comparative study of IgG and neutralising antibodies across vaccine platforms","author":"Aleissa","year":"2025"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/nejm198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1146\/annurev.immunol.21.120601.141053","article-title":"T cell dynamics in HIV-1 infection","volume":"21","author":"Douek","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1521-4141(199912)29:12<4053::aid-immu4053>3.3.co;2-3","article-title":"Enrichment and detection of live antigen\u2010specific CD4+ and CD8+ T cells based on cytokine secretion","volume":"29","author":"Brosterhus","year":"1999","journal-title":"Eur J Immunol"},{"key":"B8","article-title":"T cell-mediated cytotoxicity","volume-title":"Immunobiology: The Immune System in Health and Disease 5th Edition","author":"Janeway","year":"2001"},{"key":"B9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13059-017-1207-1","article-title":"The MHC locus and genetic susceptibility to autoimmune and infectious diseases","volume":"18","author":"Matzaraki","year":"2017","journal-title":"Genome Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-015-0849-y","article-title":"Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most","volume":"67","author":"van Deutekom","year":"2015","journal-title":"Immunogenetics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-4-9","article-title":"Association of HLA class I with severe acute respiratory syndrome coronavirus infection","volume":"4","author":"Lin","year":"2003","journal-title":"BMC Med Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-4-9","article-title":"Suboptimal SARS-CoV-2- specific CD8+ T cell response associated with the prominent HLA-A* 02: 01 phenotype","volume":"117","author":"Habel","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000499593","article-title":"HLA haplotype frequencies and genetic profiles of the Kuwaiti population","volume":"29","author":"Ameen","year":"2020","journal-title":"Med Princ Pract"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.24.11.649","article-title":"The molecular genetics of human chromosome 6","volume":"24","author":"Cunliffe","year":"1987","journal-title":"J Med Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2023.08.011","article-title":"HLA alleles: important pieces to the COVID-19 puzzle","volume":"44","author":"Castro-Santos","year":"2023","journal-title":"Trends Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"102498","DOI":"10.1016\/j.jiph.2024.102498","article-title":"Association between human leukocyte antigen alleles and COVID-19 disease severity","volume":"17","author":"Hajeer","year":"2024","journal-title":"J Infect Public Health"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41435-025-00328-4","article-title":"Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission","author":"Peckham","year":"2020","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-025-00328-4","article-title":"Association between HLA genetics and SARS-CoV-2 infection in a large real-world cohort","author":"Letovsky","year":"2025","journal-title":"Genes Immun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1832089\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:42:12Z","timestamp":1790246532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1832089\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":19,"alternative-id":["10.3389\/fimmu.2026.1832089"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1832089","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"article-number":"1832089"}}